UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037842
Receipt number R000043144
Scientific Title The effect of ACP for decision making : to decide cure place of elderly people with terminal cancer
Date of disclosure of the study information 2019/08/29
Last modified on 2019/09/03 14:20:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of medical provider's dialogue: to decide treatment place of cancer elderly people

Acronym

The effect of medical provider's dialogue: to decide treatment place of cancer elderly people

Scientific Title

The effect of ACP for decision making : to decide cure place of elderly people with terminal cancer

Scientific Title:Acronym

The effect of ACP for terminal cancer elderly people

Region

Japan


Condition

Condition

Terminal cancer

Classification by specialty

Geriatrics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarlyfy the effect of ACP for decision making to decide cure place of elderly people who is terminal cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The ratio of death in own house

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Dialogue ACP
Home visits care period
2-4 times/month
40 min./a visiting

Interventions/Control_2

Historical Control

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

1.New cancer patient of Hirose Hospital's home-based medicine, and historical control.
2.The patients of available dialogue with healthcare providers.
3.The patients of voluntary decision under informed consent.

Key exclusion criteria

1.The patients of unavailable with dialogue in first interview.
2.The participants in other clinical research past three months.
3.Inappropriate patient to particiate this study under the decision of PI.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name SHINICHIRO
Middle name
Last name SHIOZAWA

Organization

Hirose Hospital

Division name

Supporting Center for Clinical Research

Zip code

252-0105

Address

Kubosawa 2-3-16, Midoriku, Sagamihara city, Kanagawa, Japan

TEL

0427823021

Email

research@hirose-hospital.com


Public contact

Name of contact person

1st name SHINICHIRO
Middle name
Last name SHIOZAWA

Organization

Hirose Hospital

Division name

Supporting Center for Clinical Research

Zip code

252-0105

Address

Kubosawa 2-3-16, Midoriku, Sagamihara city, Kanagawa, Japan

TEL

0427823021

Homepage URL


Email

research@hirose-hospital.com


Sponsor or person

Institute

Hirose Hospital

Institute

Department

Personal name



Funding Source

Organization

Hirose Hospital

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

MINS

Address

Dogenzaka 1-15-14 2F, Shibuyaku, Tokyo, Japan

Tel

0364161868

Email

npo-mins@j-irb.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 05 Month 31 Day

Date of IRB

2019 Year 06 Month 03 Day

Anticipated trial start date

2019 Year 09 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 08 Month 29 Day

Last modified on

2019 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043144


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name